Largest 52-Week Gains
4.08k followers • 30 symbols Watchlist by Yahoo Finance
Follow this list to discover and track stocks with the greatest 52-week gain. These are stocks whose price has increased the most over the past 52 weeks (percent change). This list is generated daily, the gains are based on today's closing price and limited to the top 30 stocks that meet the criteria.
30 symbols
SHOP338.31-18.32%
Shopify Inc.
ROKU147.55-0.23%
Roku, Inc.
EBR-B10.94-0.35%
Centrais Elétricas Brasileiras S.A. - Eletrobras
EBR10.55-0.48%
Centrais Elétricas Brasileiras S.A. - Eletrobras
SE31.03-0.30%
Sea Limited
MKTX330.29-14.85%
MarketAxess Holdings Inc.
BYND155.983.02%
Beyond Meat, Inc.
KL42.38-1.48%
Kirkland Lake Gold Ltd.
SBS12.41-0.27%
Companhia de Saneamento Básico do Estado de São Paulo - SABESP
UI116.62-1.60%
Ubiquiti Inc.
AU18.84-0.75%
AngloGold Ashanti Limited
AYX112.17-1.83%
Alteryx, Inc.
GH77.500.45%
Guardant Health, Inc.
PLAN46.27-1.64%
Anaplan, Inc.
ACAD40.451.31%
ACADIA Pharmaceuticals Inc.
CIG-C3.94-0.05%
Companhia Energética de Minas Gerais
CIG3.47-0.09%
Companhia Energética de Minas Gerais
AZUL37.32-1.05%
Azul S.A.
ALLK85.421.78%
Allakos Inc.
ONCE104.77-0.88%
Spark Therapeutics, Inc.
GFI4.53-0.22%
Gold Fields Limited
SEDG76.124.48%
SolarEdge Technologies, Inc.
CZZ15.24-0.08%
Cosan Limited
ELP12.20-0.33%
Companhia Paranaense de Energia - COPEL
SBGL4.54-0.18%
Sibanye Gold Limited
GOL17.05-0.54%
GOL Linhas Aéreas Inteligentes S.A.
LSCC20.93-0.08%
Lattice Semiconductor Corporation
ARCE43.070.57%
Arco Platform Limited
TTEC47.290.11%
TTEC Holdings, Inc.
AVP4.58-0.01%
Avon Products, Inc.
- Investor's Business Daily Video
SHOP Breaks Support
Shopify undercut its 50-day line. The e-commerce software leader was among the last big software winners to break support. Long-time holders should likely wait to see if weekly loss/volume very heavy before selling.STOCK MARKET TODAY is sponsored by Interactive Brokers. To open an account, go to ibkr.com/whyib
- Zacks
Lattice Semiconductor (LSCC) Dips More Than Broader Markets: What You Should Know
Lattice Semiconductor (LSCC) closed at $20.93 in the latest trading session, marking a -0.38% move from the prior day.
- Market Realist
Generac Challenges Enphase Energy, SolarEdge Duopoly
Short-seller Citron Research noted that Generac Holdings could challenge solar microinverter makers Enphase Energy and SolarEdge's duopoly.
- Zacks
The Zacks Analyst Blog Highlights: AGCO, Alphabet, KLA, Microsoft and Lattice Semiconductor
The Zacks Analyst Blog Highlights: AGCO, Alphabet, KLA, Microsoft and Lattice Semiconductor
- Zacks
LATAM Airlines' Traffic and Load Factor Increase in August
LATAM Airlines' (LTM) traffic increases in August driven by strong demand for air travel.
- IPO-Edge.com
Tech Showing Some SaaS: Software Stocks Near Key Level to Bounce – All Star Charts
Anaplan, Inc., CrowdStrike Holdings, Inc., Okta, Inc. - some of the most resilient technology stocks have recently slipped to a key level and are poised for a possible bounce. That's according to All Star Charts, which pointed out software is approaching oversold territory. "Most Technology subsectors like Cloud Computing, Cybersecurity, and Internet, have been […]
- Zacks
US Solar Consumption on the Rise: 3 Stocks to Buy
Recent developments in the solar industry are making solar stocks attractive investment options.
- Investing.com
StockBeat: Netflix Climbs on Piper Jaffray Backing Despite Competition
Investing.com – Netflix (NASDAQ:NFLX) climbed higher on Friday after Piper Jaffray backed the streaming giant to continue its dominance, even as rivals eye a piece of the pie.
- Zacks
Kirkland Lake Gold (KL) is an Incredible Growth Stock: 3 Reasons Why
Kirkland Lake Gold (KL) possesses solid growth attributes, which could help it handily outperform the market.
- Zacks
5 Tech Stocks to Buy on a Likely US-China Interim Trade Deal
Intellectual property theft by Chinese companies in the guise of producing goods for the American tech giants is the rationale behind the Trump administration's imposition of tariffs.
- Zacks
Kirkland Lake Gold (KL) Stock Sinks As Market Gains: What You Should Know
In the latest trading session, Kirkland Lake Gold (KL) closed at $43.86, marking a -1.22% move from the previous day.
- Zacks
Roku (ROKU) Stock Sinks As Market Gains: What You Should Know
Roku (ROKU) closed the most recent trading day at $147.78, moving -1.32% from the previous trading session.
- Zacks
Momentum ETFs & Stocks in Focus as Trump Delays Tariff Hike
While the broader stock market is expected to move higher, momentum investing will likely take charge as investors seek higher returns in a short span.
- Zacks
SBGL vs. AEM: Which Stock Is the Better Value Option?
SBGL vs. AEM: Which Stock Is the Better Value Option?
- Zacks
5 Tariff-Sensitive Stocks to Buy as China Softens Stance
China has, recently, declared tariff exemptions on a number of U.S. goods, a move viewed by many as a show of good gesture just days ahead of planned talks to resolve a long-drawn-out trade issue.
- Bloomberg
Guardant Health May Be Unlikely Victim of WeWork Valuation Woes
(Bloomberg) -- WeWork’s contentious initial public offering may be hitting another key SoftBank investment: Guardant Health Inc.Guardant’s stock dropped as much as 7.8% Wednesday amid reports that SoftBank is seeking to postpone WeWork’s IPO on concerns over falling valuations. With Guardant returning more than three times its 2018 offering price of $19, it may be the best bet for SoftBank’s Vision Fund to raise cash.WeWork needs to raise at least $3 billion through an IPO to tap into an additional $6 billion credit line that bankers have been setting up in recent weeks. According to a Financial Times report in May, the Softbank Vision Fund was looking to use stakes in Guardant, Uber Technologies Inc. and Slack Technologies Inc. as collateral for a $4 billion loan.The fund is Guardant’s largest holder with a nearly 30% stake, according to data compiled by Bloomberg. The companies are in a joint venture to speed up commercialization of Guardant’s cancer tests across Asia, the Middle East and Africa. Guardant and SoftBank did not immediately respond to requests for comment.To contact the reporters on this story: Cristin Flanagan in New York at cflanagan1@bloomberg.net;Joshua Fineman in New York at jfineman@bloomberg.netTo contact the editors responsible for this story: Catherine Larkin at clarkin4@bloomberg.net, Steven Fromm, Mark MilianFor more articles like this, please visit us at bloomberg.com©2019 Bloomberg L.P.
- Zacks
Apple Expands Portfolio, Unveils Latest iPhone, iPad & Watch
Apple (AAPL) boosts its portfolio with the launch of latest iPhone, new iPad and Pencil device, Watch 5, Arcade and Apple TV+.
- Zacks
Avon (AVP) Surges 59% in 6 Months: Will Momentum Sustain?
Avon (AVP) is progressing well on its 'Open Up Avon' strategy. The company remains committed to attaining its long-term financial targets. However, soft trends in the EMEA segment remain a concern.
- Zacks
Estee Lauder (EL) Up 44% in a Year: Factors Driving the Stock
Estee Lauder (EL) focuses on enhancing travel retail business. Also, robust online network bodes well.
- Zacks
5 Top-Ranked Tech Stocks That Surged More Than 50% YTD
Here are five top-ranked technology stocks that have put up stellar price performance so far this year. The stocks have strong fundamentals and are well poised to gain in the remainder of 2019.
- Zacks
Zacks.com featured highlights include: Boot Barn, Kirkland, Ally, Alibaba and Zumiez
Zacks.com featured highlights include: Boot Barn, Kirkland, Ally, Alibaba and Zumiez
- Zacks
Here's Why You Should Add Enphase Energy (ENPH) Stock Now
Enphase Energy (ENPH) is a promising pick for investors, courtesy of these four factors.
- Market Realist
Why Is Roku Stock Tanking Today?
Roku (ROKU) stock has fallen 10.7% today to $143.75, 18.6% below its 52-week low. The streaming platform's stock has fallen 16% over the last two days.
- Zacks
ACADIA Surges on Early Success of Nuplazid Dementia Study
ACADIA Pharmaceuticals' (ACAD) Parkinson's psychosis drug, Nuplazid, meets primary endpoint earlier than expected in late-stage label expansion study evaluating it in patients with dementia-related psychosis.
